[The tachythymoleptic action of melitracene: use in reactive depressions and in neurotic inhibitions (272 cases)].
D000275:Adjustment Disorders / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002648:Child; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009450:Neurodermatitis / Q000188:drug therapy; D011600:Psychopharmacology; D011602:Psychophysiologic Disorders / Q000188:drug therapy; D011931:Reactive Inhibition; D012075:Remission, Spontaneous; D013950:Thymus Gland / Q000187:drug effects*; D014149:Tranquilizing Agents / Q000494:pharmacology
D000928:Antidepressive Agents; D014149:Tranquilizing Agents
Pouvoir tachythymanaleptique du mélitracène: indication dans les dépressions réactionnelles et les inhibitions névrotiques (272 cas)